115 studies found for:    Open Studies | "Amyloidosis"
Show Display Options
Rank Status Study
21 Recruiting Study of SOM0226 in Familial Amyloid Polyneuropathy
Condition: Familial Amyloid Polyneuropathy (FAP)
Intervention: Drug: SOM0226
22 Recruiting Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Condition: Relapsed or Refractory Systemic Light Chain Amyloidosis
Interventions: Drug: IXAZOMIB;   Drug: Dexamethasone;   Drug: Melphalan;   Drug: Cyclophosphamide;   Drug: Thalidomide;   Drug: Lenalidomide
23 Not yet recruiting Treatment of AL Amyloidosis
Condition: Amyloidosis
Intervention: Drug: Daratumumab
24 Recruiting ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)
Conditions: Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC);   Amyloidosis, Hereditary;   Amyloid Neuropathies, Familial;   Amyloid Neuropathies;   Amyloidosis, Hereditary, Transthyretin-Related;   Familial Transthyretin Cardiac Amyloidosis
Interventions: Drug: Revusiran (ALN-TTRSC);   Drug: Sterile Normal Saline (0.9% NaCl)
25 Recruiting Body Composition in Systemic Amyloidosis
Condition: Amyloidosis
Intervention: Other: Dietary advice
26 Not yet recruiting Prevalence of Amyloidosis and Carpal Tunnel
Condition: Amyloid Neuropathy, Carpal Tunnel
Intervention:
27 Recruiting Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy
Conditions: Intracerebral Hemorrhage;   Cerebral Amyloid Angiopathy;   Ischemic Stroke
Intervention:
28 Recruiting Molecular Imaging of Primary Amyloid Cardiomyopathy
Conditions: Amyloidosis, Primary;   Cardiomyopathy
Interventions: Radiation: F-18 florbetapir/C-11 acetate PET;   Device: MRI
29 Not yet recruiting Daratumumab for the Treatment of Patients With AL Amyloidosis
Condition: AL Amyloidosis
Intervention: Drug: daratumumab
30 Recruiting Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Conditions: Plasma Cell Dyscrasias;   Monoclonal Gammopathy of Undetermined Significance;   AL Amyloidosis;   Multiple Myeloma
Intervention: Procedure: tissue banking
31 Not yet recruiting Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis
Condition: AL Amyloidosis
Intervention: Drug: NEOD001
32 Recruiting First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD
Conditions: Light Chain Deposition Disease;   Primary Systemic Amyloidosis
Interventions: Drug: pomalidomide;   Drug: bortezomib;   Drug: dexamethasone;   Other: Laboratory Biomarker Analysis
33 Recruiting The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis
Condition: Primary Systemic (AL) Amyloidosis
Interventions: Drug: NEOD001;   Other: Placebo
34 Not yet recruiting Methods of Etiological Diagnosis of Cerebral Amyloid Angiopathy
Conditions: Cerebral Amyloid Angiopathy;   Intracerebral Hemorrhage
Intervention:
35 Not yet recruiting The Effect of an Antisense Oligonucleotide to Lower Transthyretin (TTR) Levels on the Progression of -Wild-type TTR Involving the Heart
Condition: Amyloidosis
Intervention: Drug: Isis 420915/GSK 299872
36 Recruiting Amyloïd Load in Elderly Population: Effect of Cognitive Reserve
Conditions: Plaque, Amyloid;   Cognitive Deficits
Interventions: Other: PET;   Other: MRI;   Other: neuropsychological tests
37 Recruiting Escitalopram Effects on CSF Amyloid Beta
Condition: Amyloid Beta Protein
Intervention: Drug: Escitalopram or Placebo
38 Recruiting Biomarker for Patients With Transthyretin-Related Familial Amyloidotic Polyneuropathy
Conditions: Metabolic Diseases;   Amyloid Neuropathies;   Amyloidosis, Familial;   Polyneuropathies
Intervention:
39 Not yet recruiting Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis
Conditions: Amyloid Cerebral Angiopathy;   Alzheimer Disease
Interventions: Device: Pet scan with FBB;   Device: MRI scan;   Biological: APO E genotyping
40 Recruiting Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction
Condition: Amyloid-beta
Interventions: Drug: Sodium Oxybate;   Behavioral: Sleep deprivation

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years